drugset
drugset / Trial / NCT00622375

PK Study of Encapsulated Mesalamine Granules in Healthy Volunteers

NCT00622375 ↗

Phase 1 Completed 24 enrolled Bausch Health Americas, Inc.
NaSingle-groupOpen-labelBasic science

Summary

The current study is being conducted to evaluate the relative bioavailability and single- and multiple-dose pharmacokinetics of encapsulated mesalamine granules(eMG) in healthy subjects.

Timeline

Start
2008-02
Primary completion
2008-02
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesalamine Small molecule — Oral

Indications

No indication recorded.